共 50 条
- [45] Addition of PD-1/PD-L1 inhibitors to chemotherapy for triple-negative breast cancer: a meta-analysis FRONTIERS IN ONCOLOGY, 2024, 14
- [47] Durable clinical response to the multidisciplinary management of neurosurgery, radiation and chemoimmunotherapy in a patient with PD-L1/PD-L2/JAK2 (PDJ)-amplified, refractory triple-negative breast cancer JOURNAL OF THE NATIONAL CANCER CENTER, 2021, 1 (03): : 115 - 121
- [48] Gene expression and soluble protein level of PD-1 and its ligands (PD-L1 and PD-L2) in endometrial cancer PLOS ONE, 2025, 20 (03):
- [49] Anti-PD-L1 for metastatic triple-negative breast cancer LANCET ONCOLOGY, 2015, 16 (06): : E264 - E264